Skip to content

Epidural Labor Analgesia and Infant Neurobehavior

Epidural Analgesia for Labor Pain and Infant Neurobehavior

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00987441
Acronym
ELAIN
Enrollment
1200
Registered
2009-10-01
Start date
2009-09-30
Completion date
2011-07-31
Last updated
2011-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Labor Pain

Keywords

Neurobehavior, Epidural analgesia, Local anesthetic, Opioid

Brief summary

Infant neurobehavior alteration is predictor of later intelligence development. Many factors would influence or are associated with infant neurobehavior, of which exist or appear during perinatal period. Neuraxial, especially epidural, analgesia to date is the most effective method in relieving labor pain. Although previous studies showed that opioid used in epidural analgesia for labor pain can affect newborn neurobehavior negatively in a dose-escalation associated manner, whether epidural analgesia itself would produce unpredictable effect on newborn neurobehavior is still unknown. Hereby the investigators designed this trial to investigate the hypothesis that epidural analgesia for labor pain control itself would not produce negative effect on infant neurobehavior.

Interventions

Ropivacaine 0.125% plus sufentanil 0.3 microgram

Sponsors

Nanjing Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
19 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* \>18years and \<45years * Spontaneous labor * Analgesia request

Exclusion criteria

* Allergy to opioids, a history of the use of centrally-acting drugs of any sort, chronic pain and psychiatric diseases records * Participants younger than 18 years or older than 45 years * Those who were not willing to or could not finish the whole study at any time * Using or used in the past 14 days of the monoamine oxidase inhibitors * Alcohol addictive or narcotic dependent patients were excluded for their influence on the analgesic efficacy of the epidural analgesics * Subjects with a nonvertex presentation or scheduled induction of labor

Design outcomes

Primary

MeasureTime frame
Neurobehavior evaluation with the Assessment of Preterm Infants' Behavior (APIB)Immediate after birth (0 min)

Secondary

MeasureTime frame
Umbilical-cord gases analysisAt the time baby was born (0min)
Neonatal sepsis evaluationOne hour after the baby was born
Apgar scoringOne min and 5min after birth.
Incidence of maternal side effectsAnalgesia initiation (0min) to successful vaginal delivery (this time encountered alteration with different women)
Neurobehavior evaluation with the Assessment of Preterm Infants' Behavior (APIB)10min after birth
Neonatal antibiotic treatmentOne hour after the baby was born

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026